AnBogen Therapeutics, a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients, announces that U.S. Food and Drug...
Regen BioPharma, Inc. announced initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical...
Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies, announced today that...
The MedTech company NeoDynamics has received approval for its innovative pulse biopsy system NeoNavia® from the US Food and Drug Administration, FDA.
The US breast...
